PPD Development Ireland Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Ireland
- Registered address
- Building C, Ida Business and Technology Park, Garrycastle, Athlone, Co. Westmeath , Ireland (IRL)
- Operations here
- analysis
- FDA identifiers
- FEI 3008676264 · DUNS 985036175
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-03-09
- VAIDrug Quality Assurance2019-07-19
- NAIDrug Quality Assurance2016-06-22
- VAIDrug Quality Assurance2011-11-09
Drugs this plant is listed as making
6 distinct drugs across 12 products name this site in their FDA label.
- Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtlBioverativ Therapeutics Inc.
- DaratumumabJanssen Biotech, Inc.
- fitusiranGenzyme Corporation
- guselkumabJanssen Biotech, Inc.
- ustekinumabJanssen Biotech, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.